The True Monthly Cost of GLP-1: Beyond the Sticker Price

The number on a GLP-1 provider's landing page is a marketing figure, not a budget. The price you actually pay over a year is shaped by three things that rarely appear in the big font: teaser rates that step up, dose escalation, and fees. This is WeighLab's signature calculation — the true monthly cost — and once you see it, you cannot un-see it.

Trap 1: the teaser rate that steps up

The most common gap between advertised and actual cost is the intro rate. A provider advertises, say, $99 for your first month, and the price steps up to $199 from month two onward. Do the math: month one at $99 plus eleven months at $199 is about $2,290 for the year — an effective average of roughly $191 per month, nearly double the number that got you in the door. A truly flat price, like the one CoreAge Rx publishes, costs the same in month twelve as in month one, which is why price transparency is a weighted factor in our methodology. When you compare providers, compare the month-twelve price, not the month-one hook. Two live versions of the same shape, from our August 2026 bench: The Edit's $109 semaglutide is a $100-off first order sitting in front of a standing $209, and Lighter You leads with a $99 that matches no program it sells. Telos Rx shows both halves of the trap at once and is worth studying for it: on its oral tirzepatide plans it prints the first month and the standing rate side by side — $49 then $129 on the longest plan, $199 then $229 with no commitment — while every injectable card quotes only a struck-through intro figure and will not name a standing price until you are inside the intake. When only one of those two numbers is published, the published one is the hook.

Trap 1b: the price that isn't quoted per month at all

A subtler version of the same problem is a rate that looks monthly and is not. Luvo Health charges every four weeks, so what reads as $249 a month is thirteen charges across a calendar year rather than twelve — roughly one extra payment you did not budget for. The same page headlines "Starting at $45/week", which is its 52-week prepay total divided out, not a rate anyone pays week to week. Before you compare any two providers, confirm you are comparing the same unit: per four weeks, per calendar month, and per 90-day supply are three different things wearing the same dollar sign.

Trap 2: dose escalation

GLP-1 medications are not started at the full dose. In the pivotal semaglutide trial, the dose was titrated up over about 16 weeks to reach the 2.4 mg target¹, and tirzepatide is similarly escalated over months in its trial program² — see the exact FDA-labeled titration schedule for both molecules. That matters for your wallet because some providers price by dose: the low sticker is the starting dose, and your cost rises as you titrate toward a therapeutic level. A provider with genuinely flat pricing across doses protects you here; one with dose-tiered pricing means your steady-state cost is higher than the introductory number. Always ask what the price is at the dose you will actually maintain. Tirzepatide in particular carries its own annual math worth isolating — see the cheapest tirzepatide over a full year for the molecule-specific ranking.

Trap 3: the fees around the medication

The medication price is not always the whole bill. Watch for a separate initial consultation fee, ongoing membership or coaching subscriptions that cannot be unbundled, lab charges, and shipping. Some of these add real value; the problem is only when they are not disclosed up front. A bundled coaching subscription you cannot cancel independently is both a cost and a flexibility hit — it shows up in our contract-flexibility scoring for that reason. If insurance covers part of your bill, the fees that survive prior authorization are a separate wildcard worth checking — see GLP-1 insurance coverage and prior authorization for what typically does and doesn't get approved, and Medicare, Medicaid and HSA/FSA rules if a government payer or a tax-advantaged account is part of your specific math.

The true-cost formula

Put it together into one number:

True annual cost = (month-one price) + (11 × maintenance-dose monthly price) + (one-time fees) + (recurring non-medication fees × 12)

Then divide by 12 for your true monthly cost. Which price you feed in matters as much as the formula: where a provider publishes two rates for the same product, use the one with no strings on it — a provider that prints both a subscribe rung and a no-commitment rung is showing you a $30-to-$40 monthly gap and letting you choose which one to budget. Run that on every finalist and the rankings often reorder — the "cheapest" provider on sticker price frequently is not the cheapest once step-ups and dose tiers are in. The cost calculators do this arithmetic for you, and the compare tool lines finalists up on the honest number.

Why this is the only number that matters

A GLP-1 program is a year-long purchase, and a medication you cannot afford to continue stops delivering results the moment you stop paying — see what actually happens when you stop a GLP-1 before treating cost pressure as a reason to quit outright rather than switch providers. Optimizing for the lowest month-one sticker is how people end up over budget by spring and off treatment by summer. Optimizing for the lowest true annual cost — from a verified provider you can actually stay with — is how you protect both your results and your wallet, and that is the single axis our cheapest GLP-1 over 12 months ranking ranks on. That is the entire premise of the Cost-Efficiency Index: rank on what you will really pay, not on what you were shown first. Every ranking we publish on that basis is indexed on the rankings page. Start with our monthly cost guide, see the full cash-pay picture in how much a GLP-1 costs without insurance, then price your own year. Everything we publish on these costs, with its sources, is collected in our research library.